🔗 Share this article

Grammy-winning R&B singer D’Angelo died on the fourteenth of October at 51 years old after a personal fight with pancreatic malignancy.

“The shining star of our household has faded away for us in the present world,” his relatives stated. “After a lengthy and brave struggle with the disease, we are heartbroken to declare that Michael D’Angelo Archer, known to his followers around the globe as D’Angelo, has been taken from us.”

D’Angelo left an indelible mark on the music industry with his innovative neo-soul sound and collaborations with high-profile artists.

He released his debut album, “Brown Sugar,” in 1995 to instant praise. The record achieved the fourth spot on Billboard’s Top R&B Albums chart, went platinum later that year, and earned multiple award nominations.

However, it was his second album, “Voodoo,” in 2000 that propelled his artistic journey into the stratosphere. The record debuted at No. 1 on each of the R&B charts and the main album chart. He won two Grammys: Best R&B Album and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a icon, albeit a reluctant one, in the cultural zeitgeist. The intimate portrayal showed the singer, notably stripped down to his midsection, performing directly into the camera.

D’Angelo stepped back from the public eye after releasing Voodoo and openly battled with substance abuse. In 2005, he was involved in a severe car crash that left him in grave health.

More than a decade later, his last record, “Black Messiah” (2014), confirmed his lasting popularity with a further No. 1 debut on the soul music rankings and a Grammy for Top R&B Record.

Again, in his own enigmatic fashion, D’Angelo had limited public outings in the following years.

The singer was announced as a headliner for the 2025 music event, but his performance was called off, due to an “unexpected health issue.”

Although details are sparse about D’Angelo’s health in the months before his passing, he had reportedly been in the hospital for an extended period and in palliative care for a fortnight.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic cancer, one of the most deadly and hardest to prevent types of the disease, on a gifted artist whose existence was cut short.

“We are grieved that he can only provide dear memories with his loved ones, but we are forever thankful for the legacy of deeply emotional music he has left us,” his kin said.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic cancer impacts the digestive organ, a small organ that produces the hormone insulin and is vital in digestion, among additional roles. The size and location of the pancreas in the body make it more difficult to identify cancer.

Even though pancreatic cancer accounts for only about 3% of malignancy cases each year in the United States, it is causes 7% of malignancy fatalities.

Nearly seventy thousand individuals will be found to have pancreatic cancer and roughly 52,000 will die of the disease in 2025.

“This malignancy is one of the deadliest cancers, with an fast-growing mass and poor prognosis. We have limited and poor treatment options, and a smaller window to make a meaningful impact on the lives of people,” noted a cancer specialist.

Since this disease seldom produces initial signs, it’s frequently identified only after the condition is advanced. Even when a patient has indicators they are usually nonspecific and may be confused with a several everyday ailments.

“As of yet, there is no good way to detect this malignancy in the early stages, except for listening to your body and speaking with your doctor if there are unfamiliar symptoms,” explained a medical director.

Common symptoms of pancreatic cancer encompass:

• abdominal or lower back pain
• reduced body mass
• jaundice
• reduced hunger
• dark urine
• light-colored or greasy stools
• diarrhea
• increased appetite or thirst
• feeling sick

At age 51, D’Angelo’s death is an exception, as this malignancy is most common in individuals in the sixty-five to seventy-five range. However, numerous malignancies, such as pancreatic cancer, have become increasingly prevalent in younger people.

“This disease identified before the age of 50 is deemed uncommon, yet concerningly, clinicians are noticing a growing number of younger patients affected by this disease,” said a specialist.

Family History Affects Disease Probability

Without effective detection methods for this malignancy, professionals emphasized the importance of knowing your relatives’ health background. Some contributing elements, such as smoking and obesity also have an influence in the onset of this disease.

African Americans have the greatest occurrence of pancreatic cancer in the U.S. and are most likely to be found to have inoperable cancer.

“The first step toward reducing one’s chance of pancreatic cancer is assessing personal risk factors. People should review their family history, hereditary factors, and medical conditions, such as blood sugar disease, long-term pancreas inflammation, or overweight that may raise their susceptibility,” advised a medical professional.

Hereditary risk factors are linked to as much as ten percent of all pancreatic cancer cases. If someone in your household has had this disease, you may want to think about genetic testing.

“For people with a relative’s background of this condition or those having high risk genetic mutations, checking may involve advanced imaging such as MRI scans or internal ultrasound to find early changes in the organ,” he explained.

For those wishing to reduce their risk, habit adjustments may have an effect. The most effective action you can take to lower your risk of pancreatic cancer is to quit smoking, and if you are a non-smoker, stay away altogether.

Excessive drinking is associated with pancreas inflammation, a risk factor for pancreatic cancer, so limiting or abstaining from drinks may assist lower your chance.

Controlling your body mass or losing weight may also help decrease your susceptibility. Individuals with excess weight are 20% more likely to get pancreatic cancer. This malignancy also occurs more often in those with diabetes, and reducing weight can also reduce the risk of type 2 diabetes.

In spite of pancreatic cancer’s grim outlook, there is still hope.

“We are doing better with treatments and more recent mixed drug treatments. There are developing precision medicines that already are showing results,” remarked a expert.

For numerous people, however, awareness about this rare but {dev